Skip to main content

Table 1 Changes in visual acuity and OCT after intravitreal anti-VEGF treatments in patients

From: Evaluation of efficacy and recurrence for anti-vascular endothelial growth factor therapy in idiopathic choroidal neovascularization

Times

Eyes

BCVA (letters)

CRT(μm)

Baseline

35

56.20 ± 14.13

353.6 ± 98.70

End of the first follow-up period

35

73.31 ± 12.57

273.1 ± 53.56

Z

 

−4.481

−4.574

Pa

 

< 0.001

< 0.001

  1. a Statistical analysis performed by the Wilcoxon Signed Ranks Test
Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us